Shareholders' Deficit (Details Textual)					1 Months Ended							12 Months Ended
	Oct. 03, 2018 USD ($) shares	Sep. 21, 2018 USD ($)	Jul. 16, 2018 USD ($)	Jun. 06, 2018 USD ($) Individuals $ / shares shares	Aug. 31, 2018 USD ($) $ / shares shares	Aug. 16, 2018	Jul. 18, 2018 USD ($) $ / shares shares	Jun. 30, 2018 USD ($) shares	Feb. 12, 2018	Aug. 31, 2017 USD ($) shares	Mar. 28, 2012 USD ($)	Dec. 31, 2018 USD ($) Transactions $ / shares shares	Dec. 31, 2017 USD ($) Transactions $ / shares shares	Jan. 03, 2018 shares	Sep. 04, 2014 shares	Sep. 03, 2014 shares
Shareholders' Deficit (Textual)
Common stock issued for services, shares | shares								277,147		276,850
Net proceeds from issuance of common stock								$ 31,688		$ 49,996
Aggregate grant date fair value of warrants issued												$ 130,306
Fair value of warrant												296,447
General and administrative expense												$ 2,840,784	$ 1,848,866
Authorized shares of common stock | shares												500,000,000	500,000,000
Preferred shares | shares															20,000,000	20,000,000
Michael Dent [Member]
Shareholders' Deficit (Textual)
Common stock issued for services, shares | shares	100,000
Risk-free interest rate									2.56%
Expected life (in years)									5 years
Expected volatility rate									268.90%
Aggregate grant date fair value of warrants issued											$ 337,466
Purchase price of common stock	$ 5,000
Common Stock [Member]
Shareholders' Deficit (Textual)
Proceeds from sale of stock												$ 417,500	$ 288,000
Sale of stock, shares | shares												3,534,891	1,461,111
Sale of stock, per share | $ / shares													$ 0.30
Recognized expenses												$ 49,556	$ 58,265
Common stock issued for services, shares | shares												93,440	47,101
Warrants to purchase shares of common stock | shares												2,649,798	959,998
Number of private placement transactions | Transactions												6	3
Warrant terms												5 years	5 years
Common Stock [Member] | Investment Agreement [Member]
Shareholders' Deficit (Textual)
Proceeds from sale of stock												$ 440,523	$ 27,640
Sale of stock, shares | shares												2,440,337	222,588
Maximum [Member]
Shareholders' Deficit (Textual)
Authorized shares of common stock | shares														500,000,000
Maximum [Member] | Common Stock [Member]
Shareholders' Deficit (Textual)
Sale of stock, per share | $ / shares												$ 0.35	$ .20
Warrant to purchase of common stock exercise price | $ / shares												0.45
Minimum [Member]
Shareholders' Deficit (Textual)
Authorized shares of common stock | shares														230,000,000
Minimum [Member] | Common Stock [Member]
Shareholders' Deficit (Textual)
Sale of stock, per share | $ / shares												0.085	$ .18
Warrant to purchase of common stock exercise price | $ / shares												$ 0.15
Employee Equity Incentive Plan [Member]
Shareholders' Deficit (Textual)
Common stock issued for services, shares | shares												15,503,680
Unrecognized stock compensation												$ 103,452
Stock based compensation recognized for grants												$ 28,678	$ 11,153
Employee Equity Incentive Plan [Member] | Common Stock [Member]
Shareholders' Deficit (Textual)
Obligated to issue shares to employee | shares												0	75,000
July 2018 Private Placement [Member]
Shareholders' Deficit (Textual)
Gross proceeds							$ 1,999,590
Net proceeds from private placement							$ 1,774,690
Placement agent warrants issued | shares							640,000
Warrants to purchase shares of common stock | shares							1,360,000
Warrant to purchase of common stock exercise price | $ / shares							$ 0.0001
Securities purchase agreement, description			(1) an aggregate of 3,900,000 shares of the Company's common stock, par value $0.0001 per share, (2) Pre-Funded Warrants to purchase an aggregate of 4,100,000 shares of Company common stock with an exercise price of $0.0001 and a five-year life, (3) Series A Warrants to purchase 8,000,000 shares of Company common stock with an exercise price of $0.25 per share, subject to anti-dilution and other adjustment as described below, and a term of five years, and (4) Series B Warrants to purchase up to a maximum of 17,000,000 shares of Company common stock, subject to adjustment as described below, at a fixed exercise price of $0.0001. On July 18, 2018, the Company and the investors consummated the transaction. The Company received gross proceeds of $1,999,590. After investor legal fees of $15,000 and placement agent fees of $209,900, net proceeds to the Company were $1,774,690. The Company also issued to the placement agent 640,000 Series A Warrants with the same terms as the investor's Series A Warrants and Series B Warrants to purchase up to a maximum of 1,360,000 shares of Company common stock at an exercise price of $0.0001.
Legal fees							$ 15,000
Placement agent fees							209,900
Financing cost							$ 623,216
Employee Stock Option [Member]
Shareholders' Deficit (Textual)
Stock based compensation recognized for grants												$ 73,954	$ 9,779
Series A Warrants [Member]
Shareholders' Deficit (Textual)
Loss on change in fair value of derivative liabilities		$ 385,856
Derivative liabilities		2,071,680
Series B Warrants [Member]
Shareholders' Deficit (Textual)
Loss on change in fair value of derivative liabilities		385,856
Derivative liabilities		$ 711,692
Five-year warrants [Member]
Shareholders' Deficit (Textual)
Issued warrants | shares				600,000
Fair value of warrant				$ 94,844
Warrant to purchase of common stock exercise price | $ / shares				$ 0.15
Warrant terms				5 years
General and administrative expense												94,844
Number of individuals | Individuals				2
Five-year warrants [Member] | Consultant services [Member]
Shareholders' Deficit (Textual)
Issued warrants | shares					400,000
Fair value of warrant					$ 145,861
Warrant to purchase of common stock exercise price | $ / shares					$ 0.35
Warrant terms					5 years
General and administrative expense												$ 145,861
Warrant [Member]
Shareholders' Deficit (Textual)
Issued warrants | shares												27,635,819	9,949,998
Risk-free interest rate, minimum												2.32%	1.74%
Risk-free interest rate, maximum												2.93%	2.01%
Risk-free interest rate		2.95%	2.77%
Expected life (in years)		4 years 9 months 25 days	5 years										5 years
Expected volatility rate		298.82%	288.00%
Expected dividend yield		$ 0	$ 0									$ 0	$ 0
Aggregate grant date fair value of warrants issued												$ 464,546	$ 629,299
Net proceeds from private placement			$ 1,774,690
Warrants, description			(1) because the Series A Warrants were not settled at a fixed price, these instruments did not qualify for equity classification and were recorded as derivative financial instruments with an inception date fair value of $1,984,722, (2) because the Series B Warrants were not settled into a fixed number of shares, these instruments did not qualify for equity classification and were recorded as derivative financial instruments with an inception date fair value of $412,794, (3) the Pre-Funded Warrants were settled into a fixed number of shares at a fixed price and were classified as equity with an inception date fair value of $942,988.			(1) the exercise price of the Series A Warrants issued to the investors and the placement agent was reduced from $0.25 to $0.2233, and (2) the number of Series B Warrants issuable was set at 2,745,757 for the investors and 219,660 for the placement agent. At the Repricing Date, the exercise price of the Series A Warrants and the number of shares issuable pursuant to the Series B Warrants was fixed.
Warrant [Member] | Maximum [Member]
Shareholders' Deficit (Textual)
Expected life (in years)												5 years
Expected volatility rate												308.60%	190.86%
Warrant [Member] | Minimum [Member]
Shareholders' Deficit (Textual)
Expected life (in years)												3 years
Expected volatility rate												261.18%	40.00%
Additional Paid-in Capital [Member]
Shareholders' Deficit (Textual)
Fair value of warrant												$ 296,447